Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-11-13

Clinical Trial Update: Ultrahypofractionation and Normal Tissue Toxicity [NA]

View source ↗

Summary

This clinical trial update from Massachusetts General Hospital discusses ultrahypofractionation radiotherapy for breast cancer and its impact on normal tissue t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Breast Cancer, Breast Cancer Female | NA | Status: ACTIVE_NOT_RECRUITING